146 References 1. Crouser ED, Maier LA, Baughman RP, et al. Diagnosis and detection of sarcoidosis an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):E26-E51. doi:10.1164/RCCM.202002-0251ST 2. Drent M, Strookappe B, Hoitsma E, De Vries J. Consequences of sarcoidosis. Clin Chest Med. 2015;36(4):727-737. doi:10.1016/j.ccm.2015.08.013 3. Voortman M, Hendriks CMR, Elfferich MDP, et al. The burden of sarcoidosis symptoms from a patient perspective. Lung. 2019;197(2):155-161. doi:10.1007/s00408-019-00206-7 4. Lacomis D. Small-fiber neuropathy. Muscle and Nerve. 2002;26(2):173-188. doi:10.1002/mus.10181 5. Bakkers M, Faber CG, Hoeijmakers JGJ, Lauria G, Merkies ISJ. Small fibers, large impact: Quality of life in small-fiber neuropathy. Muscle and Nerve. 2014;49(3):329-336. doi:10.1002/mus.23910 6. Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385(11):1018-1032. doi:10.1056/NEJMra2101555 7. Sharma R, Kouranos V, Cooper LT, et al. Management of cardiac sarcoidosis. Eur Heart J. 2024;00:1-30. doi:10.1093/eurheartj 8. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Hear Rhythm. 2014;11(7):1304-1323. doi:10.1016/j.hrthm.2014.03.043 9. Gawałko M, Balsam P, Lodziński P, et al. Cardiac arrhythmias in autoimmune diseases. Circ J. 2020;84(5):685-694. doi:10.1253/circj.CJ-19-0705 10. Zalewski P, Słomko J, Zawadka-Kunikowska M. Autonomic dysfunction and chronic disease. Br Med Bull. 2018;128(1):61-74. doi:10.1093/bmb/ldy036 11. Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956-962. doi:10.2337/diacare.28.4.956 12. Hoitsma E, Faber CG, Van Kroonenburgh MJPG, et al. Association of small fiber neuropathy with cardiac sympathetic dysfunction in sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis. 2005;22(1):43-50. 13. Oishi M, Mukaino A, Kunii M, et al. Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies. J Neurol. 2021;268(11):4265-4279. doi:10.1007/s00415-021-10551-4 LK 14. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8(5):491-498. doi:10.2337/diacare.8.5.491 15. Pstras L, Thomaseth K, Waniewski J, Balzani I, Bellavere F. The Valsalva manoeuvre: physiology and clinical examples. Acta Physiol. 2016;217(2):103-119. doi:10.1111/apha.12639 16. Scholte AJHA, Schuijf JD, Delgado V, et al. Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123Imetaiodobenzylguanidine myocardial scintigraphy and heart rate variability. Eur J Nucl Med Mol Imaging. 2010;37(9):1698-1705. doi:10.1007/s00259-010-1442-0 17. Mostard RLM, Vöö S, van Kroonenburgh MJPG, et al. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med. 2011;105(12):1917-1924. doi:10.1016/j.rmed.2011.08.012 18. Bloom HL, Vinik AI, Colombo J. Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results. Heart Int. 2014;9(1):15-21. 19. Smulders NM, Bast A, van Kroonenburgh MJPG, Drent M. Improvement of cardiac sympathetic nerve function in sarcoidosis. Sarcoidosis, Vasc Diffus lung Dis Off J WASOG. 2008;25(2):140142. 9 152 9
RkJQdWJsaXNoZXIy MjY0ODMw